Wegovy® (semaglutide) is available online through two legitimate channels: an FDA-approved prescription reviewed by a licensed clinician and filled by a licensed pharmacy — including, for some patients, Novo Nordisk's own NovoCare self-pay channel — or, when a clinician determines a different product fits your history better, a separate compounded semaglutide option. Every legitimate path starts the same way: an online health questionnaire that a US-licensed clinician actually reviews before anything is prescribed. This guide walks through how that process works, where Wegovy® fits next to Ozempic®, and how to spot a seller that isn't legitimate at all.
The short answer
Wegovy® is FDA-approved for chronic weight management and made by Novo Nordisk. Getting it online legitimately means a licensed clinician reviews your health history and prescribes it if appropriate, then a licensed pharmacy — a standard retail/mail-order pharmacy or Novo Nordisk's own NovoCare self-pay channel — fills it. Eligibility is determined by a US-licensed clinician, and any seller shipping it without that review isn't a shortcut, it's outside the law.
What is Wegovy®, and who is it FDA-approved for?
Wegovy® is Novo Nordisk's brand name for semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist. It was FDA-approved in 2021 for chronic weight management in adults with obesity, or overweight with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol, alongside a reduced-calorie diet and increased physical activity. It ships as a single-dose pen — Wegovy® has no multi-dose KwikPen or vial format.
Semaglutide is also sold under a second brand name, Ozempic® — same active ingredient, same manufacturer, but approved separately in 2017 specifically for improving blood sugar control in adults with type 2 diabetes, and topping out at a lower maximum dose. Which product is appropriate depends on your diagnosis, not on which is easier to find: a clinician treating obesity or overweight with a weight-related condition prescribes Wegovy®, and a clinician treating type 2 diabetes prescribes Ozempic®. See our full Ozempic® vs. Wegovy® comparison for how the two differ. Learn more about semaglutide treatment at Pallas.
How does getting a Wegovy® prescription online actually work?
The process is the same regardless of which licensed telehealth provider you use:
- Complete a health questionnaire. You'll share your medical history, current medications, any prior GLP-1 use, relevant labs if you have them, and your state of residence — a clinician must be licensed where you're physically located.
- A US-licensed clinician reviews it. This is a real clinical decision, not a formality — a provider that approves everyone regardless of history is a red flag, not a convenience. Eligibility is determined by a US-licensed clinician.
- If appropriate, a prescription is sent to a licensed pharmacy. That can be a standard retail or mail-order pharmacy, or, for some patients, Novo Nordisk's own NovoCare self-pay channel.
- The pharmacy fills and ships your prescription. Most telehealth intakes take 5–10 minutes, and many states allow the entire process — including the clinician review — to happen without a live video visit. Telehealth rules vary by state; see our guide to how online GLP-1 prescriptions work for the full process.
See if Wegovy® is right for you
A US-licensed clinician reviews your health history and determines whether Wegovy® or another option is appropriate for you.
Start your intake →What are the legitimate ways to buy Wegovy® online?
Two, and only two:
- A prescription for FDA-approved Wegovy®, written by a licensed clinician after reviewing your health history, filled by a licensed pharmacy.
- A compounded semaglutide preparation, when your clinician documents that it — rather than Wegovy® or Ozempic® — is the appropriate option for you (more on this below).
Anything that skips the clinician review, or ships semaglutide with no prescription at all, isn't a third, cheaper option. It's outside the law and outside any oversight of what's actually in the pen.
What about NovoCare?
NovoCare is Novo Nordisk's own self-pay channel, and it's a legitimate source — it's operated by the manufacturer itself. It can be a lower-cost way to get genuine Wegovy® for eligible self-pay patients. This article intentionally doesn't quote prices, since self-pay pricing changes and isn't something a third-party source should hand-type — see our semaglutide cost breakdown for current figures. Whichever licensed pharmacy fills it, NovoCare or otherwise, the product is the same FDA-approved medication — the channel changes, the drug doesn't.
Is compounded semaglutide a substitute for Wegovy®?
Not a substitute — a separate option your clinician may consider if Wegovy® or Ozempic® isn't the right fit for you. Compounded semaglutide is prepared per-patient by a US-licensed compounding pharmacy under FDCA §503A when a clinician documents a patient-specific clinical rationale. It is a different, and separately regulated, product from Wegovy®.
Compounded medications are prepared on a per-patient basis by US-licensed compounding pharmacies, regulated under federal law (FDCA §503A) and by state boards of pharmacy. While these pharmacies are highly regulated, the compounded medications themselves are not FDA-approved, are not generic versions of brand-name drugs, and have not been evaluated by the FDA for safety, efficacy, or quality. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary.
A clinician might consider it when, for example, a specific dose or formulation isn't available as Wegovy® or Ozempic®, or another documented clinical reason applies — cost or preference alone isn't a sufficient basis under current FDA guidance. Your clinician decides which option, if any, is appropriate for you.
How do I spot an illegitimate online Wegovy® seller?
The warning signs are consistent, whether the listing says "Wegovy," "generic semaglutide," or a made-up product name entirely:
- No prescription required. Semaglutide is a prescription medication everywhere in the US. Any seller willing to ship it without a clinician's review is operating outside the law.
- "Research use only" or "not for human use" labeling. This signals the product isn't intended, tested, or regulated as a medicine for people — not a legal workaround.
- The seller won't name its pharmacy. A legitimate provider can tell you exactly which licensed pharmacy — retail, NovoCare, or a named compounding pharmacy — fills your order.
- No verifiable certification. LegitScript maintains a public database of certified healthcare merchants. Check any provider — including Pallas — before paying.
- A price that seems too good to be true. Wegovy® is a complex biologic to manufacture. A price far below what named, licensed sources charge, from a seller that won't say where the product comes from, points to a counterfeit or unregulated-sourcing risk, not a bargain.
Two free lookups cover most of the verification: LegitScript's certification database for the provider, and the FDA's BeSafeRx locator to confirm the pharmacy itself is state-licensed.
Does insurance cover Wegovy® ordered online?
It depends on the pharmacy and your plan. Through a standard retail or mail-order pharmacy, coverage for Wegovy® varies widely by plan, and many commercial insurers require prior authorization or exclude weight-loss indications entirely. Through Pallas, brand-name Wegovy® is $1,349/mo cash-pay — not billed to insurance. Medicare is prohibited by law from covering medications prescribed for weight loss, so Medicare does not cover Wegovy® regardless of pharmacy.
Where does Pallas fit?
Pallas is LegitScript Healthcare Merchant Certified, and every Wegovy® prescription starts with a real intake reviewed by a US-licensed clinician. Pallas dispenses FDA-approved Wegovy® through US-licensed pharmacies on a cash-pay basis, and separately offers compounded semaglutide, prepared by US-licensed compounding pharmacies, when a clinician documents it's the appropriate option. Both are cash-pay; insurance is not billed, and eligibility is always determined by a US-licensed clinician. Learn more about semaglutide treatment at Pallas or see the full semaglutide cost breakdown.
Frequently asked questions
Start a telehealth intake and share your health history, current medications, and state of residence — it takes about five minutes. A US-licensed clinician reviews your intake and, if Wegovy® is clinically appropriate for you, sends the prescription to a licensed pharmacy, which can be a standard retail or mail-order pharmacy or, for some patients, Novo Nordisk's own NovoCare self-pay channel. Eligibility is determined by a US-licensed clinician, and Wegovy® dispensed through Pallas is cash-pay only, not billed to insurance.
They're the same active ingredient — semaglutide, made by Novo Nordisk — but FDA-approved for different reasons. Wegovy® is approved for chronic weight management; Ozempic® is approved for type 2 diabetes and tops out at a lower maximum dose. Which one a clinician prescribes depends on your diagnosis, not on which is easier to find.
No, not legally. Semaglutide is a prescription medication in the US. Any seller shipping Wegovy® without a health questionnaire and a licensed clinician's review is operating outside the law, regardless of how the listing is labeled.
NovoCare is Novo Nordisk's own self-pay channel — a legitimate source, since it's operated by the manufacturer. It can be a lower-cost way for eligible self-pay patients to get genuine Wegovy®. Check NovoCare directly for current pricing and availability.
It's a separate option, not a substitute. Compounded semaglutide is prepared per-patient by a US-licensed compounding pharmacy under FDCA §503A when a clinician documents a patient-specific clinical rationale — it is not FDA-approved, not a generic version of Wegovy® or Ozempic®, and has not been evaluated by the FDA for safety, efficacy, or quality. A clinician decides whether it's appropriate for you; cost or preference alone isn't a sufficient basis.
Check for a real health questionnaire and a US-licensed clinician's review (not just a payment form), a named licensed pharmacy filling your order, no willingness to ship without a prescription, and verifiable LegitScript certification — LegitScript maintains a public database you can search before paying any provider, including Pallas.
References
- U.S. Food and Drug Administration. WEGOVY® (semaglutide) prescribing information. 2026.
- U.S. Food and Drug Administration. FDA's Concerns With Unapproved GLP-1 Drugs Used for Weight Loss. 2026.
- U.S. Food and Drug Administration. Locate a State-Licensed Online Pharmacy (BeSafeRx). 2024.
Bottom line: Legitimate Wegovy® online comes from a licensed clinician's review followed by a licensed pharmacy — a standard pharmacy or Novo Nordisk's own NovoCare self-pay channel — filling an FDA-approved prescription. Compounded semaglutide is a separate, non-equivalent option a clinician may consider when Wegovy® or Ozempic® isn't the right fit. A seller offering semaglutide with no prescription, no named pharmacy, or no verifiable certification isn't a shortcut to a better price — it's outside the system that makes any of this safe to trust.
Check your eligibility with a licensed clinician
Complete a short health questionnaire, and a US-licensed clinician will review your history and determine whether Wegovy® is appropriate for you — no obligation, no membership fee.
Start your intake →Trademarks & disclosures
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk. Pallas is not affiliated with, endorsed by, or sponsored by Novo Nordisk. Brand-name semaglutide dispensed through Pallas is cash-pay only and is not billed to insurance. Prescriptions — brand-name or compounded — are written only when a US-licensed clinician determines treatment is appropriate.